| List Name |
Annotation |
Enrichment |
p-value |
| positive regulation of lymphocyte differentiation |
AmiGO Browser |
50.57 |
7.17e-04 |
| regulation of defense response |
AmiGO Browser |
32.36 |
1.77e-03 |
| regulation of inflammatory response |
AmiGO Browser |
32.36 |
1.77e-03 |
| negative regulation of myeloid cell differentiation |
AmiGO Browser |
29.97 |
2.06e-03 |
| regulation of lymphocyte differentiation |
AmiGO Browser |
26.97 |
2.54e-03 |
| regulation of response to stimulus |
AmiGO Browser |
25.28 |
2.88e-03 |
| lymphocyte differentiation |
AmiGO Browser |
9.48 |
4.10e-03 |
| menstrual cycle phase |
AmiGO Browser |
20.75 |
4.26e-03 |
| menstrual cycle process |
AmiGO Browser |
20.75 |
4.26e-03 |
| menstrual cycle |
AmiGO Browser |
18.82 |
5.16e-03 |
| female gonad development |
AmiGO Browser |
17.59 |
5.88e-03 |
| development of primary female sexual characteristics |
AmiGO Browser |
17.21 |
6.14e-03 |
| female sex differentiation |
AmiGO Browser |
17.21 |
6.14e-03 |
| hemopoiesis |
AmiGO Browser |
5.34 |
7.17e-03 |
| protein folding |
AmiGO Browser |
5.07 |
8.55e-03 |
| B cell differentiation |
AmiGO Browser |
14.19 |
8.91e-03 |
| hemopoietic or lymphoid organ development |
AmiGO Browser |
5.01 |
8.92e-03 |
| leukocyte differentiation |
AmiGO Browser |
6.63 |
0.01 |
| immune system development |
AmiGO Browser |
4.68 |
0.01 |
| positive regulation of T cell activation |
AmiGO Browser |
12.45 |
0.01 |
| regulation of myeloid cell differentiation |
AmiGO Browser |
10.93 |
0.01 |
| positive thymic T cell selection |
AmiGO Browser |
67.42 |
0.01 |
| positive T cell selection |
AmiGO Browser |
67.42 |
0.01 |
| reproductive structure development |
AmiGO Browser |
10.79 |
0.02 |
| gonad development |
AmiGO Browser |
10.79 |
0.02 |
| positive regulation of lymphocyte activation |
AmiGO Browser |
10.37 |
0.02 |
| development of primary sexual characteristics |
AmiGO Browser |
10.24 |
0.02 |
| negative regulation of protein catabolic process |
AmiGO Browser |
57.79 |
0.02 |
| multicellular organism reproduction |
AmiGO Browser |
9.75 |
0.02 |
| reproductive process in a multicellular organism |
AmiGO Browser |
9.75 |
0.02 |
| positive regulation of survival gene product activity |
AmiGO Browser |
50.57 |
0.02 |
| negative regulation of cell differentiation |
AmiGO Browser |
8.99 |
0.02 |
| regulation of T cell activation |
AmiGO Browser |
8.99 |
0.02 |
| positive regulation of inflammatory response |
AmiGO Browser |
44.95 |
0.02 |
| positive regulation of defense response |
AmiGO Browser |
44.95 |
0.02 |
| rhythmic process |
AmiGO Browser |
8.61 |
0.02 |
| protein ubiquitination |
AmiGO Browser |
8.43 |
0.02 |
| negative regulation of catabolic process |
AmiGO Browser |
40.45 |
0.02 |
| regulation of epithelial cell differentiation |
AmiGO Browser |
36.78 |
0.03 |
| peptide or protein amino-terminal blocking |
AmiGO Browser |
36.78 |
0.03 |
| negative regulation of defense response |
AmiGO Browser |
36.78 |
0.03 |
| myoblast fusion |
AmiGO Browser |
36.78 |
0.03 |
| negative regulation of inflammatory response |
AmiGO Browser |
36.78 |
0.03 |
| sex differentiation |
AmiGO Browser |
7.63 |
0.03 |
| positive regulation of T cell differentiation |
AmiGO Browser |
33.71 |
0.03 |
| chaperone cofactor-dependent protein folding |
AmiGO Browser |
33.71 |
0.03 |
| regulation of steroid metabolic process |
AmiGO Browser |
33.71 |
0.03 |
| T cell homeostasis |
AmiGO Browser |
33.71 |
0.03 |
| regulation of B cell differentiation |
AmiGO Browser |
33.71 |
0.03 |
| protein modification by small protein conjugation |
AmiGO Browser |
7.49 |
0.03 |
| lymphocyte activation |
AmiGO Browser |
4.51 |
0.03 |
| negative regulation of developmental process |
AmiGO Browser |
7.36 |
0.03 |
| organ development |
AmiGO Browser |
2.10 |
0.03 |
| antigen processing and presentation of exogenous antigen |
AmiGO Browser |
31.12 |
0.03 |
| skeletal morphogenesis |
AmiGO Browser |
31.12 |
0.03 |
| T cell differentiation in the thymus |
AmiGO Browser |
31.12 |
0.03 |
| thymic T cell selection |
AmiGO Browser |
31.12 |
0.03 |
| protein stabilization |
AmiGO Browser |
31.12 |
0.03 |
| regulation of lymphocyte activation |
AmiGO Browser |
7.10 |
0.03 |
| B cell activation |
AmiGO Browser |
7.04 |
0.03 |
| reproductive developmental process |
AmiGO Browser |
6.97 |
0.03 |
| N-terminal protein amino acid modification |
AmiGO Browser |
28.90 |
0.03 |
| centrosome cycle |
AmiGO Browser |
28.90 |
0.03 |
| positive regulation of activated T cell proliferation |
AmiGO Browser |
28.90 |
0.03 |
| regulation of cell activation |
AmiGO Browser |
6.92 |
0.03 |
| positive regulation of body size |
AmiGO Browser |
26.97 |
0.04 |
| posttranslational protein folding |
AmiGO Browser |
26.97 |
0.04 |
| pathogenesis |
AmiGO Browser |
26.97 |
0.04 |
| regulation of protein catabolic process |
AmiGO Browser |
25.28 |
0.04 |
| leukocyte activation |
AmiGO Browser |
3.98 |
0.04 |
| regulation of activated T cell proliferation |
AmiGO Browser |
23.80 |
0.04 |
| transcription from RNA polymerase I promoter |
AmiGO Browser |
23.80 |
0.04 |
| positive regulation of interleukin-2 biosynthetic process |
AmiGO Browser |
23.80 |
0.04 |
| T cell selection |
AmiGO Browser |
22.47 |
0.04 |
| microtubule organizing center organization and biogenesis |
AmiGO Browser |
22.47 |
0.04 |
| centrosome organization and biogenesis |
AmiGO Browser |
22.47 |
0.04 |
| lymphocyte homeostasis |
AmiGO Browser |
21.29 |
0.05 |
| cell-cell adhesion |
AmiGO Browser |
3.73 |
0.05 |
| C21-steroid hormone metabolic process |
AmiGO Browser |
20.23 |
0.05 |
| sequestering of lipid |
AmiGO Browser |
20.23 |
0.05 |
| myeloid cell differentiation |
AmiGO Browser |
5.70 |
0.05 |
| immune effector process |
AmiGO Browser |
5.66 |
0.05 |
| cell activation |
AmiGO Browser |
3.68 |
0.05 |
| homeostasis of number of cells |
AmiGO Browser |
19.26 |
0.05 |
| regulation of survival gene product activity |
AmiGO Browser |
19.26 |
0.05 |
| regulation of protein stability |
AmiGO Browser |
19.26 |
0.05 |
| regulation of interleukin-2 biosynthetic process |
AmiGO Browser |
19.26 |
0.05 |
| leukocyte homeostasis |
AmiGO Browser |
19.26 |
0.05 |
| cell fate specification |
AmiGO Browser |
18.39 |
0.05 |
| smoothened signaling pathway |
AmiGO Browser |
18.39 |
0.05 |
| calcium ion transport |
AmiGO Browser |
5.32 |
0.05 |
| regulation of T cell differentiation |
AmiGO Browser |
17.59 |
0.06 |
| natural killer cell activation |
AmiGO Browser |
17.59 |
0.06 |
| calcium-independent cell-cell adhesion |
AmiGO Browser |
17.59 |
0.06 |
| lactation |
AmiGO Browser |
16.86 |
0.06 |
| activated T cell proliferation |
AmiGO Browser |
16.86 |
0.06 |
| regulation of catabolic process |
AmiGO Browser |
16.86 |
0.06 |
| DNA recombination |
AmiGO Browser |
5.12 |
0.06 |
| positive regulation of B cell activation |
AmiGO Browser |
16.18 |
0.06 |
| ovarian follicle development |
AmiGO Browser |
15.56 |
0.06 |
| regulation of erythrocyte differentiation |
AmiGO Browser |
15.56 |
0.06 |
| regulation of mRNA stability |
AmiGO Browser |
15.56 |
0.06 |
| positive regulation of growth |
AmiGO Browser |
14.98 |
0.06 |
| regulation of RNA stability |
AmiGO Browser |
14.98 |
0.06 |
| immune system process |
AmiGO Browser |
2.14 |
0.07 |
| interleukin-2 biosynthetic process |
AmiGO Browser |
14.45 |
0.07 |
| interleukin-2 production |
AmiGO Browser |
14.45 |
0.07 |
| T cell activation |
AmiGO Browser |
4.68 |
0.07 |
| antigen processing and presentation of peptide or polysaccharide antigen via MHC class II |
AmiGO Browser |
13.95 |
0.07 |
| cell differentiation |
AmiGO Browser |
1.71 |
0.07 |
| cellular developmental process |
AmiGO Browser |
1.71 |
0.07 |
| system development |
AmiGO Browser |
1.71 |
0.07 |
| myoblast development |
AmiGO Browser |
12.64 |
0.08 |
| myoblast maturation |
AmiGO Browser |
12.64 |
0.08 |
| positive regulation of progression through cell cycle |
AmiGO Browser |
12.26 |
0.08 |
| regulation of lipid metabolic process |
AmiGO Browser |
12.26 |
0.08 |
| regulation of body size |
AmiGO Browser |
12.26 |
0.08 |
| mismatch repair |
AmiGO Browser |
11.90 |
0.08 |
| somatic diversification of immunoglobulins |
AmiGO Browser |
11.90 |
0.08 |
| somatic diversification of immune receptors |
AmiGO Browser |
11.90 |
0.08 |
| maintenance of fidelity during DNA-dependent DNA replication |
AmiGO Browser |
11.56 |
0.08 |
| regulation of RNA metabolic process |
AmiGO Browser |
11.56 |
0.08 |
| positive regulation of T cell proliferation |
AmiGO Browser |
11.56 |
0.08 |
| biogenic amine biosynthetic process |
AmiGO Browser |
11.24 |
0.09 |
| meiotic recombination |
AmiGO Browser |
10.93 |
0.09 |
| di-, tri-valent inorganic cation transport |
AmiGO Browser |
4.03 |
0.09 |
| multicellular organism growth |
AmiGO Browser |
10.65 |
0.09 |
| female gamete generation |
AmiGO Browser |
10.65 |
0.09 |
| regulation of B cell activation |
AmiGO Browser |
10.65 |
0.09 |
| immunoglobulin production |
AmiGO Browser |
10.37 |
0.09 |
| leukocyte migration |
AmiGO Browser |
10.37 |
0.09 |
| symbiosis, encompassing mutualism through parasitism |
AmiGO Browser |
10.11 |
0.09 |
| interspecies interaction between organisms |
AmiGO Browser |
10.11 |
0.09 |
| mRNA catabolic process |
AmiGO Browser |
9.87 |
0.10 |
| male sex differentiation |
AmiGO Browser |
9.87 |
0.10 |
| positive regulation of lymphocyte proliferation |
AmiGO Browser |
9.41 |
0.10 |
| positive regulation of mononuclear cell proliferation |
AmiGO Browser |
9.41 |
0.10 |
L2L Microarray Analysis Tool